Refractory B Lymphoblastic Lymphoma: Clinical Trials

3 trials for Refractory B Lymphoblastic Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 not yet recruiting. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Active not recruiting 1, Completed 1, Not yet recruiting 1
Phase 21Active not recruiting 1

Follow Refractory B Lymphoblastic Lymphoma: new trials by email Literature Review of Refractory B Lymphoblastic Lymphoma trials Research Report on Refractory B Lymphoblastic Lymphoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma
Autologous BAFFR-targeting CAR T Cells, Biospecimen Collection, Bone Marrow Aspiration - Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma
Phase 1Not yet recruitingCity of Hope Medical Center162027-04-172026-08-11
Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia
Etoposide, Doxorubicin, Vincristine - Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma
Phase 1CompletedUniversity of Washington242019-09-242023-07-06
Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia
Biospecimen Collection, Computed Tomography, Lumbar Puncture - Recurrent Adult Lymphoblastic Lymphoma, Recurrent B Acute Lymphoblastic Leukemia
Phase 1 / Phase 2Active not recruitingECOG-ACRIN Cancer Research Group402018-08-132026-10-06

Narrower conditions

Burkitt Lymphoma (3)  ·  Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (3)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

DNA Virus Infections (3)  ·  Epstein-Barr Virus Infections (3)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Herpesviridae Infections (3)  ·  Immune System Diseases (3)  ·  Immunoproliferative Disorders (3)  ·  Infections (3)  ·  Leukemia (3)  ·  Leukemia, Lymphoid (3)  ·  Lymphatic Diseases (3)  ·  Lymphoma (3)  ·  Lymphoma, B-Cell (3)  ·  Lymphoma, Non-Hodgkin (3)  ·  Lymphoproliferative Disorders (3)

Interventions

Cyclophosphamide (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  Specimen Handling (2)  ·  Vincristine (2)  ·  Biopsy (1)  ·  Bridge Therapy (1)  ·  Doxorubicin (1)  ·  Etoposide (1)  ·  Inotuzumab Ozogamicin (1)  ·  Leukapheresis (1)  ·  Prednisone (1)  ·  Spinal Puncture (1)  ·  X-Rays (1)  ·  fludarabine (1)  ·  venetoclax (1)

Sponsors

City of Hope Medical Center (1)  ·  ECOG-ACRIN Cancer Research Group (1)  ·  University of Washington (1)

Countries

United States (3)  ·  Puerto Rico (1)

Top investigators

Ibrahim Aldoss (1)  ·  Neil D Palmisiano (1)  ·  Ryan Cassaday (1)

Results publications

PMID 38722664, PMID 39415930

NIH funding

P30CA033572 (1), U10CA180820 (1)